Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2015

Feb 6, 2015

30718_dirs_2015-02-06_4015eb1b-5489-47bb-b8ba-df89b82dd894.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-02-05

Reporting Person: Dinarello Charles A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-05 Common Stock M 1500 $54.91 Acquired 5500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-05 Stock Option $54.91 M 1500 Disposed 2015-11-28 Common Stock (1500) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $91.78 2024-10-29 Common Stock (4000) 4000 Direct
Stock Option $87.39 2023-10-30 Common Stock (4000) 4000 Direct
Stock Option $66.9 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct
Stock Option $63.03 2019-10-28 Common Stock (5000) 5000 Direct
Stock Option $65.47 2018-10-22 Common Stock (5000) 5000 Direct
Stock Option $66.59 2017-10-24 Common Stock (5000) 5000 Direct
Stock Option $56.17 2016-10-25 Common Stock (5000) 5000 Direct